IE61012B1 - Container for freeze drying under sterile conditions - Google Patents

Container for freeze drying under sterile conditions

Info

Publication number
IE61012B1
IE61012B1 IE154189A IE154189A IE61012B1 IE 61012 B1 IE61012 B1 IE 61012B1 IE 154189 A IE154189 A IE 154189A IE 154189 A IE154189 A IE 154189A IE 61012 B1 IE61012 B1 IE 61012B1
Authority
IE
Ireland
Prior art keywords
membrane
container according
container
drying
freeze drying
Prior art date
Application number
IE154189A
Other versions
IE891541L (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IE891541L publication Critical patent/IE891541L/en
Publication of IE61012B1 publication Critical patent/IE61012B1/en

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26DRYING
    • F26BDRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Drying Of Solid Materials (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

For the freeze-drying of, in particular, biological or pharmaceutical material under sterile conditions, the material to be dried is placed in a container whose sides are at least partly composed of a hydrophobic, porous, germproof membrane which is permeable to water vapour, the container is closed pressure-tight and then the material is freeze-dried in the closed container under usual conditions.

Description

The present invention is concerned with a container for freeze drying under sterile conditions, especially for the drying of biological and/or pharmaceutical material.
In the case of biological and pharmaceutical materials, it is frequently necessary to store the materials completely dry until they are used. These sensitive substances are mostly only obtainable by freeze drying,. Furthermore, as a rule, it is necessary to keep these substances completely free from microorganisms not only because of the decomposition of biological substances brought about by micro-organisms but also in order to prevent possible infections in the case of their use.
The freeze drying of biological and pharmaceutical materials is generally known (see also Ullmanns Enzyklopadie der Technischen Chemie, 3rd edition, Vol. I, p. 556 et seq.). In order to avoid a contamination of the dried material with micro-organisms and other contaminants, laborious apparatus and processtechnical measures have to be made.
In the case of drying pharmaceutical preparations in ampoules or small bottles, the procedure is, for example, to provide small bottles which contain the frozen material with a bacterial filter and to dry the material in the small bottles in a first drying step to -310 Τ ) 25 such an extent that the sublimation of the frozen solvent is concluded.
Subsequently, in a second drying stage, i.e. the so-called post or residual drying», the still remaining residual moisture is removed from the material. Since this second drying step is usually carried out in a special apparatus- the ampoules or vials must be removed from the first drying apparatus in a further working step which is prone to contamination and introduced into the second drying apparatus. For this purposes the bacterial filter is removed and replaced by an aluminium cap provided with a rubber diaphragm and a hollow needle. After a residual drying for several days depending upon the nature of the material to be drieds the drying chamber is filled with an inert gas and with slight overpressure and the diaphragm opening closed as vapour-tightly as possible by a grouting mass.
Since the speed of sublimation in the case of this type of freeze drying is only about half as great as that of openly spread out material, the freeze drying of biological and pharmaceutical material is also carried out on plates under sterile conditions.
A solution of the material to be dried is thereby first sterilised5 for example by filtration over a sterile filters subsequently poured under sterile conditions on to plates and freeze dried by means of known methods. -4However, a prerequisite of this process is that the whole of the freeze drying plant can be sterilised. Furthermore, it is also necessary to keep the surroundings of the drying plant free from micro-organisms.
After drying has taken place, it is necessary to remove the material in the drying plant itself or in its surroundings with mechanical processes from the plates under sterile conditions and to fill it into also sterile storage containers. This process requires laborious plant and sterile chambers, as well as an especially careful working with the material to be dried or already dried until it is confectioned ready for use.
From GB-A-995930, ic was already known to freezedry radio-active aqueous solutions in vapour-permeable bags and thereby to make available for the sublimation a larger surface area than in the case of drying in bottles. The problem of a microbial contamination of the material co be dried thereby does not arise..
It is an object of the present invention to overcome the above-mentioned disadvantages and to provide a simple container with the help of which freeze dried material can be obtained without the abovementioned laborious sterility requirements for the drying plant, as well as for the space surrounding this.
Thus, according to the present invention, there is provided a container for freeze drying of especially biological or pharmaceutical material under sterile conditions., characterised in chat its sides consist at least partly of two walls connected hermetically and pressure» proof with one another on their edges, one wall of which is made from liquid-tight material and che ocher wall of a hydrophobic,, porous,, germ-tight water vapourpermeable material. -5The present invention is based on the surprising finding that, contrary to expectations, the vapour flow resulting by the sublimation of solvent molecules, which flows from the material to be dried to a condenser is hindered only to a small extent by the membrane used in the process according to the present invention.
Thus, surprisingly, the freeze drying of material which is enclosed by the membrane proceeds almost equally quickly as the freeze drying of the same material when open and non-packed.
The membranes used according to the present invention are hydrophobic membranes which contain pores which, on the one hand, are permeable for water vapour buts on the other hand, are so small that microorganisms can no longer pass through. Such pores preferably have a size of <$ 0,5 pm. and especially of < 0.2 pm. Membranes are preferably used which, under the particular process conditions., are also tearproof even in a wet state. However, the container according to the present invention can also be used with less stable membranes provided that these are strengthened with a carrier -6material or are not excessively mechanically stressed.
The particularly selected proportion of the membrane on the wall surface of che container according to che present invention depends upon the particular selected conditions and the drying period and can easily be ascertained by means of simple experiments. In one embodiment preferred according to the present inventions the whole wall surface consists of the membrane film and in a further preferred embodiment about one half of the wall surface consists of che membrane film. The container according co the present invention can also be advantageously carried out when the wall surface also only consists of up co 10% of the membrane film.
In particular, there are suitable semi-permeable papers of cellulose and usual cellulose derivatives, such as cellulose acetate.
Membranes of films of polymer compounds, for example polytetrafluoroethylene or polypropylene, can also be advantageously used. Films of sterilisation paper according to German Industrial Standard DIN 58 953 are also quite especially useful as water vapour-permeable membranes. In further preferred embodiments of the present invention^ Goretex and similar membranes or also commercially available film tubes can be used. 7In principle, any film membrane can be useds regardless of its componentss provided that they fulfil the requirements with regard to micro-organism impermeability, air permeability and especially strength given in German Industrial Standard DIN 58 953.
In a preferred embodiment» the .container according to the present invention consists of a bag or tube which consists of two walls hermetically and tightly connected with one another on their edges» one wall of which consists of a liquidtight material and the other wall of the membrane.
The membrane is preferably welded or glued with the vessel. According to the present invention» troughs are especially preferred as the vessels.
In a further preferred embodiments the trough consists of liquid-impermeable synthetic resin and preferably has a wall thickness of 0.5 to 1 mm.
The most favourable drying conditions., such as pressure, temperature and amount, depend upon the particular material to be dried and the thickness of the membrane, as well as upon the size and number of the pores thereof and must be determined by usual and simple experimentation for the particular material and the packing.
The following Examples are given for the purpose of illustrating the present invention? -8Example 1.
The testing of the micro-organism impermeability of a membrane was so carried out according to German Industrial Standard DIN 58 953 that micro-organisms in water drops were applied to test pieces and,, after drying the water drops, it was ascertained whether micro-organisms have passed through to the under side of the test pieces.
The membrane film to be tested was cut up into squares of about 50 mm. edge length and the test pieces were sterilised and dried. Each test piece of the sterilised membrane was placed on a sterilised substrate with the side which can be contaminated in the case of use upwardly and inoculated with 5 drops each of 0.1 ml. (corresponding to 10θ to 10? micro-organisms).
The test pieces were stored at a temperature of 20 to 25°C. under a relative atmospheric humidity of 40 to 60%. The drops must be completely dried within 6 hours.
Each test piece was placed with the inoculated surface upwardly on the surface of a blood agar plate (1.5% agar) so that the whole film surface came into contact with the agar. After 5 to 6 seconds, the paper was removed and the plates were incubated for 16 to 25 hours at 37°C. If the agar plates treated with such film samples show no growths the film is regarded as being C sufficiently impermeable to micro-organisms. Further statements regarding the testing of the impermeability -9of membranes to micro-organisms and especially the preparation of test micro-organism suspensions, can be taken from part 6 of German Industrial Standard DIN 58 953.
Example 2.
A nutrient solution was produced which consisted of 10 g. peptone? 5 g. glucose. 5 g. sodium chloride,» 0.084 g. monopotassium dihydrogen phosphates 0.187 g. disodium hydrogen phosphate dihydrate and pyrogen-free water ad 1.0 litre and which had been adjusted to pH 7.0. Subsequently,, it was end-sterilised in a closed, piercable bottle.
For the reception of the sterile nutrient solution to be lyophilised, there was prepared a trans15 parent sterile bag consisting of a transparent film and an appropriate paper. For this purpose, a piece with a length of 800 mm. was cut off from a commercially available roll of transparent sterilisation bag film of the firm Wipak Medical, type Steri-King R 47 which is available in the form of a tube, i.e. is welded on both sides but is otherwise open, the roll having a width of 400 mm. This tube was welded on both of the open sides with a commercially available film-welding apparatus to form a bag. Subsequently, this bag was sterilised in an autoclave with filter programme at 123°C. and 2 bar vapour pressure, the sterile bag was placed with the transparent film downwardly for better -10handling in a non-sterile sheet metal trough (VA sheet metal3 dimensions: length 800 mm., breadth 400 mm., height 30 mm.) and opened in a laminar flowbox under sterile conditions with disinfected scissors by cutting off of a corner. Through this opening of about 30 mm. between the film and the paper was introduced 1.5 litres of sterile nutrient solution via a sterile tube pushed into the opening. The so filled bag was again closed in the laminar flowbox under sterile conditions by means of a commercially available film welding device by welding over the corner.
The whole assembly (sheet metal trough, bag and sterile nutrient solution) was applied to a plate pre-cooled to -45°C. of a commercially available, nonsterilisable freeze drying apparatus of the firm Edwards + Kniese with a total positioning surface of 2 1.5m and the solution frozen in. After complete freezing in of the solution under non-sterile conditions, it was freeze dried at a pressure of 10-^ mm.Hg and a plate temperature of 22°C. and the product _3 post-dried at 10 mm.Hg, again under non-sterile conditions. The total drying time was about 72 hours.
The so obtained freeze-dried material, present as a pale brown powder in the transparent sterilisation bag, was subsequently introduced into a laminar flowbox and dissolved in 1.5 litres of sterile water. For this purpose, the intended puncturing point was disinfected -11with alcohol on the paper side, by means of a sterile canula and appropriate sterile syringe a total of 1.5 litres of sterile water was introduced into the bag, the dried material dissolved and the solution transferred into a sterile bottle. This solution was incubated for 4 days at 37°C. and subsequently the micro-organism count of the incubated solution determined by the membrane filter method.
It was shown that no micro-organisms had been 10 entrained by the freeze drying.

Claims (11)

1. „ Container for freeze drying of especially biological or pharmaceutical material under sterile conditions, characterised in that its sides consist at least 5 partly of two walls connected hermetically and pressureproof with one another on their edges, one wall of which is made from liquid-tight material and the other wall of a hydrophobic, porous s germ-tight water vapourpermeable material. 10
2. , Container according to claim 1, characterised in that the pores of the membrane have a size of <^0-5 pm,.
3. Container according to claim 2 S characterised in that the pores of the membrane have a size of <· 0,.2 pm,,
4. Container according to one of claims 1 to 3,. 15 characterised in that the membrane is a film with the properties according to DIN 58 953»
5. » Container according to one of claims 1 to 4, characterised in that the membrane consists of semipermeable paper.«, preferably of cellulose and cellulose 20 derivatives.
6. ,, Container according to claim 5,, characterised in that the membrane consists of cellulose acetate.
7. Container according co claim 1 co 4 # , characterised in that the membrane is β film of a polymer compound „ 25 preferably of polytetrafluoroethylene or polypropylene.
8. Container according to claim 1 to characterised in that it is formed as tube or bag. P - 13
9. Container according to claim 1 to 7 1 , characterised in that it is formed as flask, ampoule or vial which is closed with the membrane.
10. Container according to claim 1 to 7, characterised 5 in that it is forced as trough which is connected pressure-proof with the membrane as covering.
11. A container according to claim 1 f substantially as hereinbefore described and exemplified.
IE154189A 1988-05-26 1989-05-11 Container for freeze drying under sterile conditions IE61012B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3817906A DE3817906A1 (en) 1988-05-26 1988-05-26 METHOD AND CONTAINER FOR FREEZING DRYING UNDER STERILE CONDITIONS

Publications (2)

Publication Number Publication Date
IE891541L IE891541L (en) 1989-11-26
IE61012B1 true IE61012B1 (en) 1994-09-07

Family

ID=6355171

Family Applications (1)

Application Number Title Priority Date Filing Date
IE154189A IE61012B1 (en) 1988-05-26 1989-05-11 Container for freeze drying under sterile conditions

Country Status (13)

Country Link
EP (1) EP0343596B1 (en)
JP (1) JPH0229256A (en)
AT (1) ATE73226T1 (en)
CA (1) CA1337974C (en)
DD (1) DD283864A5 (en)
DE (2) DE3817906A1 (en)
DK (1) DK173643B1 (en)
ES (1) ES2030556T3 (en)
FI (1) FI91442C (en)
GR (1) GR3004584T3 (en)
HU (1) HU204126B (en)
IE (1) IE61012B1 (en)
PL (1) PL159938B1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
US5257983A (en) * 1991-04-12 1993-11-02 Cryopharm Corporation Blood bag for lyophilization
AU7356094A (en) * 1994-04-04 1995-10-23 W.L. Gore & Associates, Inc. Improved method for minimizing contamination of freeze-dried products
EP0776297B1 (en) * 1994-08-19 1998-08-05 W.L. Gore & Associates, Inc. Vented vial for freeze-drying and method of minimizing contamination of freeze-dried products
FR2740108B1 (en) * 1995-08-22 1998-03-27 Lab Francais Du Fractionnement WATERPROOF PACKAGING FOR DRYING, ESPECIALLY LYOPHILIZATION, AND DRYING METHOD, ESPECIALLY LYOPHILIZATION, USING SUCH PACKAGING
FR2738057B1 (en) * 1995-08-22 1997-11-07 Lab Francais Du Fractionnement WATERPROOF PACKAGING FOR DRYING, ESPECIALLY LYOPHILIZATION, AND DRYING METHOD, ESPECIALLY LYOPHILIZATION, USING SUCH PACKAGING
US5958778A (en) * 1995-09-22 1999-09-28 The United States Of America As Represented By The Department Of Health And Human Services Container for drying biological samples, method of making such container, and method of using same
US5596814A (en) * 1995-11-06 1997-01-28 W. L. Gore & Associates, Inc. Vented vial stopper for processing freeze-dried products
AT1399U1 (en) 1995-11-29 1997-04-25 Immuno Ag METHOD AND DEVICE FOR LYOPHILIZING
DE19751031A1 (en) 1997-11-19 1999-06-24 Ingo Dipl Ing Heschel Process for the production of porous structures
US6312648B1 (en) 1998-01-12 2001-11-06 The United States Of America As Represented By The Department Of Health And Human Services Applicator system
DE19815993C2 (en) * 1998-04-09 2003-03-06 Schott Glas Freeze-drying containers and storage for medical products
EP1958618A1 (en) 2007-02-15 2008-08-20 Octapharma AG Method for freeze-drying with optimum reconstitution of biopolymers
JP2010124931A (en) * 2008-11-26 2010-06-10 Kanae Co Ltd Method for manufacturing package of freeze-dried medicine
EP2386399B8 (en) * 2010-04-23 2015-08-05 MC Beteiligungs-GmbH Method for making openings in a waterproof coating and base body with such coating
WO2015162273A1 (en) 2014-04-25 2015-10-29 Merck Sharp & Dohme Bv A method to dry multiple individual frozen bodies and a system for applying this method
JP7110360B2 (en) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー Freeze-drying method
JP2019090596A (en) * 2017-11-10 2019-06-13 エイブル株式会社 Method for producing freeze-dried product, freeze-drying bag, and freeze-drying device
JP7471316B2 (en) 2019-03-14 2024-04-19 テルモ ビーシーティー バイオテクノロジーズ,エルエルシー Multi-part freeze-drying container

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620147A (en) * 1961-07-17
BE622411A (en) * 1961-11-28
GB1154320A (en) * 1965-09-24 1969-06-04 Unilever Ltd Freeze Drying
FR2284842A1 (en) * 1974-09-11 1976-04-09 Nestle Sa IMPROVEMENT PROVIDES LYOPHILIZATION OF SOLID, LIQUID OR PASTE PRODUCTS
JPS60168464A (en) * 1983-11-18 1985-08-31 新技術事業団 Blood preserving method and container
JPS6136942A (en) * 1984-07-28 1986-02-21 Sony Corp Apparatus for electronic part

Also Published As

Publication number Publication date
DK173643B1 (en) 2001-05-14
DE3817906A1 (en) 1989-11-30
JPH0229256A (en) 1990-01-31
ATE73226T1 (en) 1992-03-15
IE891541L (en) 1989-11-26
EP0343596A3 (en) 1990-02-28
HUT52617A (en) 1990-07-28
DD283864A5 (en) 1990-10-24
DK252589A (en) 1989-11-27
FI91442C (en) 1994-06-27
PL159938B1 (en) 1993-01-29
EP0343596B1 (en) 1992-03-04
DK252589D0 (en) 1989-05-24
FI892563A (en) 1989-11-27
JPH0450830B2 (en) 1992-08-17
DE58900902D1 (en) 1992-04-09
EP0343596A2 (en) 1989-11-29
CA1337974C (en) 1996-01-23
FI892563A0 (en) 1989-05-25
PL279609A1 (en) 1990-01-22
ES2030556T3 (en) 1992-11-01
FI91442B (en) 1994-03-15
GR3004584T3 (en) 1993-04-28
HU204126B (en) 1991-11-28

Similar Documents

Publication Publication Date Title
US5309649A (en) Process and container for freeze drying under sterile conditions
IE61012B1 (en) Container for freeze drying under sterile conditions
KR100319565B1 (en) Self-contained biological indicator
JPS62228147A (en) Biological indicator for sterilization process
US4675159A (en) Method and device for disinfecting biological fluids and container for same
US3716961A (en) In-package sterilization
WO2006013360A1 (en) Freeze-drying apparatus
KR100827297B1 (en) Blood coagulation accelerator and vessel for blood test
US3846242A (en) Biological sterility indicator and method for using same
FR2756259A1 (en) Manufacturing dry sterile packaging for sterile articles
EP1291588B2 (en) Use of an apparatus for augmenting humidity
EP0060723B1 (en) Indicator for detecting ethylene oxide
KR970058680A (en) Preservation method of liquid diagnostic medicine
Kearney et al. Evaluation of ethylene oxide sterilization of tissue implants
Kelsey Sterilization by ethylene oxide
Denyer et al. Sterilization procedures and sterility assurance
RU2123353C1 (en) Separate-type biological indicator
Ford Sterile pharmaceutical products
Kayser Chemical sterilization with special reference to ethylene oxide
RU2123354C1 (en) Method of controlling conditions of sterilizing liquid solutions and biological indicator required for its implementation
US3380884A (en) 1, 2-epoxyalkane volatile residual space fungicides adsorbed in pelleted molecular sieves
JPH0649493B2 (en) Packaging sterilization method
FI82381C (en) Gas sterilization control indicator
SU1762935A1 (en) Method of gaseous sterilization
JP2010264059A (en) Filter system for keeping sterility

Legal Events

Date Code Title Description
MK9A Patent expired